Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Novocure, GmbH

FDA 510(k) & PMA Approved Devices — 3 products

Total Devices3
Categories3
Latest FDA decision2026-07-01
TypeNumberDevice NameCodeDateActions
PMA P230042 Electrical tumor treatment fields for non-small cell lung cancerSDA2026-07-01 View
PMA P250034 Low Electric Field Generator for Pancreatic Cancer TreatmentSHC2026-07-01 View
PMA P100034 Stimulator, low electric field, tumor treatmentNZK2026-06-04 View

Related Clinical Trials

NCT06216301LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLCRECRUITINGNCT06556563EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed GlioblastomaRECRUITINGNCT06558799LUNAR-4: Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Pembrolizumab for Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC)TERMINATED
↑